Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Shyamala C. Navada, MD, Guillermo Garcia-Manero, MD, Ehab L. Atallah, MD, M. Nabeel Rajeh, MD, Jamile M. Shammo, MD, Elizabeth A. Griffiths, MD, Samer K. Khaled, MD, Shaker R. Dakhil, MD, David E. Young, MD, Rosalie Odchimar-Reissig, RN, Afoluso Ronnee Adesanya, MD, Patrick S. Zbyszewski, MBA, Richard C. Woodman, MD, Pierre Fenaux, MD PhD, Lewis R. Silverman, MD

Blood (2019) 134 (Supplement_1): 566.

https://doi.org/10.1182/blood-2019-131676

Published: 2019

Journal Articles

Frequency and Outcome of Clinically Signficant Incidental Findings in Plasma Cell Dyscrasias Patients Undergoing Whole Body FDG PET-CT Scan

Ehsan Shabbir, MD, Sarah L Mott, Lindsay Dozeman, Umar Farooq, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Guido J. Tricot, MD PhD

Blood (2017) 130 (Supplement 1): 5376.

https://doi.org/10.1182/blood.V130.Suppl_1.5376.5376

Published: 2017

Journal Articles

Renal Safety after More Than a Decade of Deferasirox Use in Patients with Transfusional Hemosiderosis

Raffaella Origa, Antonio Piga, MD, Immacolata Tartaglione, MD, Giuseppina Della Corte, Ali El-Ali, Jackie Han, Chiara Castiglioni, Gian Luca Forni, MD

Blood (2016) 128 (22): 2466.

https://doi.org/10.1182/blood.V128.22.2466.2466

Published: 2016

Journal Articles

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Alesia Abigael Hunt, MBChB MRCP, Anjum Bashir Khan, MBChB, MRCP, Donal McLornan, MD, PhD, Majid A Kazmi, BmedBiol MB ChB MRCP(UK) MRCPath, Matthew Streetly, BMBS, MRCP, MRCPath, Victor Noriega, MD, Eithne MacMahon, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2012) 120 (21): 3040.

https://doi.org/10.1182/blood.V120.21.3040.3040

Published: 2012

Journal Articles

Impact of G-CSF on Outcomes of Pregnancy in Women with Severe Chronic Neutropenia

Laurence A. Boxer, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Lan Phan, BA, Jordan M. Bond, BA, Blanche P Alter, MD, MPH, Mary Ann Bonilla, MD, Daniel Link, MD, Peter E. Newburger, MD, Philip S. Rosenberg, PhD, Akiko Shimamura, MD, PhD, David C. Dale, MD

Blood (2011) 118 (21): 4786.

https://doi.org/10.1182/blood.V118.21.4786.4786

Published: 2011

Journal Articles

Outcomes of Pregnancies for Women with Severe Chronic Neutropenia with or without G-CSF Treatment.

Laurence A. Boxer, MD, Audrey Anna Bolyard, RN, BS, Tracy M. Marrero, Blanche P Alter, Mary Ann Bonilla, MD, Dan Link, MD, Peter E. Newburger, Philip S. Rosenberg, Akiko Shimamura, David C. Dale, MD

Blood (2010) 116 (21): 1490.

https://doi.org/10.1182/blood.V116.21.1490.1490

Published: 2010

Journal Articles

A Case of FVII Inhibitor.

Michael Joshua Levitt, MD, Arthur A. Topilow, MD, William Lerner, MD, Peter Mencel, MD, Carl Henningson, MD, David Benjamin Greenberg, MD, Claire S. Philipp, MD

Blood (2010) 116 (21): 3655.

https://doi.org/10.1182/blood.V116.21.3655.3655

Published: 2010

Journal Articles

Inotuzumab Ozogamicin (CMC-544) In Patients with Indolent B-Cell NHL That Is Refractory to Rituximab Alone, Rituximab and Chemotherapy, or Radioimmunotherapy: Preliminary Safety and Efficacy From a Phase 2 Trial

Andre Goy, MD, Joseph Leach, MD, W. Christopher Ehmann, MD, Kiyoshi Ando, MD, PhD, Kiyohiko Hatake, MD, PhD, Kensei Tobinai, MD, PhD, Tatyana Feldman, MD, Steven Hua, Angela DG Volkert, Erik R. Vandendries, MD, PhD, Michinori Ogura, MD, PhD

Blood (2010) 116 (21): 430.

https://doi.org/10.1182/blood.V116.21.430.430

Published: 2010

Journal Articles

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma.

Manish Sharma, MD, Peter Thall, PhD, Xuemei Wang, PhD, Chitra Hosing, MD, Floralyn L Mendoza, MD, Eric Han, MD, Michael Wang, MD, Donna Weber, MD, Jatin Shah, MD, Amin Alousi, MD, Paolo Anderlini, MD, Partow Kebriaei, MD, Issa F Khouri, MD, Uday Popat, MD, Marcos de Lima, MD, Richard E Champlin, MD, Sergio Giralt, MD, Muzaffar Qazilbash, MD

Blood (2009) 114 (22): 2309.

https://doi.org/10.1182/blood.V114.22.2309.2309

Published: 2009

Journal Articles

Brisk Lymphocytosis with Aberrant Expression of CD5 in the Leukemic Phase of Follicular Lymphoma.

Bijal D. Shah, MD, Elizabeth Sagatys, MD, Ling Zhang, MD, Lynn C. Moscinski, MD, Eduardo M. Sotomayor, MD

Blood (2009) 114 (22): 5033.

https://doi.org/10.1182/blood.V114.22.5033.5033

Published: 2009

Journal Articles

Late-Onset Hemorrhagic Cystitis in Children After Hematopoietic Stem Cell Transplantation (HSCT) for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir (CDV).

Javid Gaziev, Guido Lucarelli, Stefano Germani, Pierpaolo Paba, Carlo Federico Perno, Roberto Miano, Pierluigi Bove, Pietro Sodani, Antonella Isgro, Marco Marziali, Paola Polchi, Aldo Montuoro, Katia Paciaroni, Cristiano Gallucci, Maria Domenica Simone, Andrea Roveda, Gioia De Angelis, Cecilia Alfieri

Blood (2009) 114 (22): 1133.

https://doi.org/10.1182/blood.V114.22.1133.1133

Published: 2009

Journal Articles

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma

Muzaffar H. Qazilbash, Rima M. Saliba, Matteo Pelosini, M.D., Chitra M Hosing, Floralyn L Mendoza, Eric Han, Michael Wang, MD, Donna M. Weber, Amin M. Alousi, Paolo Anderlini, Partow Kebriaei, Issa F. Khouri, Uday R Popat, Marcos De Lima, Robert Z. Orlowski, MD, PhD, Richard E. Champlin, Sergio A. Giralt

Blood (2008) 112 (11): 3320.

https://doi.org/10.1182/blood.V112.11.3320.3320

Published: 2008

Journal Articles

Trauma Site Localisation of Extramedullary Plasmacytomata in Thalidomide Treated Myeloma Patients.

James Cavet, MRCPath, PhD, Hamish Hunter, MRCP, Gordon Cook, FRCPath, PhD

Blood (2006) 108 (11): 5069.

https://doi.org/10.1182/blood.V108.11.5069.5069

Published: 2006

Journal Articles

BK Viruria in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Increased Incidence in Patients Receiving Alemtuzumab (ALEM) as Conditioning Therapy and Lack of Efficacy of Cidofovir.

Terrance Comeau, MD, T. Shea, MD, D. Gabriel, MD, PhD, D. Morris, MD, R. Irons, D. Harvey, PharmD, A. Sharf, RN, C. Krasnov, C. Dunphy, MD, N. Benderenko, MD, M. Brecher, MD, J. Serody, MD, PhD

Blood (2004) 104 (11): 3160.

https://doi.org/10.1182/blood.V104.11.3160.3160

Published: 2004

NARROW

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Frequency and Outcome of Clinically Signficant Incidental Findings in Plasma Cell Dyscrasias Patients Undergoing Whole Body FDG PET-CT Scan

Renal Safety after More Than a Decade of Deferasirox Use in Patients with Transfusional Hemosiderosis

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Impact of G-CSF on Outcomes of Pregnancy in Women with Severe Chronic Neutropenia

Outcomes of Pregnancies for Women with Severe Chronic Neutropenia with or without G-CSF Treatment.

A Case of FVII Inhibitor.

Inotuzumab Ozogamicin (CMC-544) In Patients with Indolent B-Cell NHL That Is Refractory to Rituximab Alone, Rituximab and Chemotherapy, or Radioimmunotherapy: Preliminary Safety and Efficacy From a Phase 2 Trial

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma.

Brisk Lymphocytosis with Aberrant Expression of CD5 in the Leukemic Phase of Follicular Lymphoma.

Late-Onset Hemorrhagic Cystitis in Children After Hematopoietic Stem Cell Transplantation (HSCT) for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir (CDV).

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma

Trauma Site Localisation of Extramedullary Plasmacytomata in Thalidomide Treated Myeloma Patients.

BK Viruria in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Increased Incidence in Patients Receiving Alemtuzumab (ALEM) as Conditioning Therapy and Lack of Efficacy of Cidofovir.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only